MarketCapJahresabschlüsse von Unternehmen
| Name | Aktualisierungsdatum | Bericht Hinzugefügt | Berichtstyp | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Actinium Pharmaceuticals
ATNM
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American |  |
 |
Greenwich LifeSciences
GLSI
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
ClearSign Technologies Corporation
CLIR
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Kintara Therapeutics
KTRA
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Salarius Pharmaceuticals
SLRX
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Super League Gaming
SLGG
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
DISH Network Corporation
DISH
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market, SPB | |
 |
Cocrystal Pharma
COCP
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Fluent
FLNT
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Patriot National Bancorp
PNBK
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
CNS Pharmaceuticals
CNSP
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Genius Brands International
GNUS
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Enveric Biosciences
ENVB
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Ayro
AYRO
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Predictive Oncology
POAI
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
AmpliTech Group
AMPG
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
MEI Pharma
MEIP
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
STRATA Skin Sciences
SSKN
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Document Security Systems
DSS
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
American Resources Corporation
AREC
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Plexus Corp.
PLXS
|
14.11.2025 | 2025 | Geschäftsbericht | Nasdaq Global Select Market, SPB | |
 |
Clearside Biomedical
CLSD
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Eastside Distilling
EAST
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Lazydays Holdings
LAZY
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Avalon GloboCare Corp.
AVCO
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
The LGL Group
LGL
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Tectonic Financial
TECTP
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Flexible Solutions International
FSI
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American |  |
 |
Bank of the James Financial Group
BOTJ
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Summit Wireless Technologies
WISA
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Akerna Corp.
KERN
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Glen Burnie Bancorp
GLBZ
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Atmos Energy Corporation
ATO
|
14.11.2025 | 2025 | Geschäftsbericht | NYSE | |
 |
Verrica Pharmaceuticals
VRCA
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Galectin Therapeutics
GALT
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Enochian Biosciences
ENOB
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
180 Life Sciences Corp.
ATNF
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
|
Research Solutions
RSSS
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
|
First National Corporation
FXNC
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
|
CannBioRx Life Sciences Corp.
ATNFW
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
VirnetX Holding Corp
VHC
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE | |
 |
Reading International
RDI
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
VerifyMe
VRME
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
XpresSpa Group
XSPA
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Utah Medical Products
UTMD
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
First Capital
FCAP
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Inhibikase Therapeutics
IKT
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Scholar Rock Holding Corporation
SRRK
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Nicholas Financial
NICK
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Nova LifeStyle
NVFY
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
BioSig Technologies
BSGM
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Iterum Therapeutics
ITRM
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market |  |
|
7GC & Co. Holdings
VII
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Boxlight Corporation
BOXL
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Spire
SR
|
14.11.2025 | 2025 | Geschäftsbericht | NYSE, SPB | |
 |
Benitec Biopharma
BNTC
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Vallon Pharmaceuticals
VLON
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
|
FG Financial Group
FGF
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
AgEagle Aerial Systems
UAVS
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Trio-Tech International
TRT
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Aspira Women's Health
AWH
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market, SPB | |
 |
Professional Diversity Network
IPDN
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
TELA Bio
TELA
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
ZW Data Action Technologies
CNET
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market |  |
 |
Greenlane Holdings
GNLN
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Renren
RENN
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE | |
 |
GreenBox POS
GBOX
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Paramount Gold Nevada Corp.
PZG
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
MACOM Technology Solutions Holdings
MTSI
|
14.11.2025 | 2025 | Geschäftsbericht | Nasdaq Global Select Market | |
 |
Taitron Components Incorporated
TAIT
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Kentucky First Federal Bancorp
KFFB
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Hudson Global
HSON
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Precipio
PRPO
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Sensei Biotherapeutics
SNSE
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Jaguar Health
JAGX
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Air Industries Group
AIRI
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Pioneer Power Solutions
PPSI
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Repare Therapeutics
RPTX
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Seritage Growth Properties
SRG
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE | |
|
Perpetua Resources Corp.
PPTA
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Maui Land & Pineapple Company
MLP
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE | |
 |
Genprex
GNPX
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
ReneSola Ltd
SOL
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE | |
 |
ENDRA Life Sciences
NDRA
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Fortress Biotech
FBIO
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Sotherly Hotels
SOHO
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
NanoViricides
NNVC
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
BIO-key International
BKYI
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
NanoVibronix
NAOV
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Retractable Technologies
RVP
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Sonos
SONO
|
14.11.2025 | 2025 | Geschäftsbericht | Nasdaq Global Select Market, SPB | |
 |
Johnson Controls International plc
JCI
|
14.11.2025 | 2025 | Geschäftsbericht | NYSE, SPB |  |
 |
Qualigen Therapeutics
QLGN
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
|
Smith-Midland Corporation
SMID
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
American Shared Hospital Services
AMS
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Planet Green Holdings Corp.
PLAG
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
Future FinTech Group
FTFT
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Aileron Therapeutics
ALRN
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
My Size
MYSZ
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market |  |
 |
GT Biopharma
GTBP
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
ClearOne
CLRO
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Palatin Technologies
PTN
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
|
Eledon Pharmaceuticals
ELDN
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Ohio Valley Banc Corp.
OVBC
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
|
Forte Biosciences
FBRX
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Regional Health Properties
RHE
|
14.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American | |
 |
SPAR Group
SGRP
|
14.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
ORIC Pharmaceuticals
ORIC
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Comstock Holding Companies
CHCI
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
|
Galera Therapeutics
GRTX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Onconova Therapeutics
ONTX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Landmark Bancorp
LARK
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Flux Power Holdings
FLUX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Fennec Pharmaceuticals
FENC
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Omeros Corporation
OMER
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Second Sight Medical Products
EYES
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Greenpro Capital Corp.
GRNQ
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Dawson Geophysical Company
DWSN
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
|
Duos Technologies Group
DUOT
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Acasti Pharma
ACST
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Sally Beauty Holdings
SBH
|
13.11.2025 | 2025 | Geschäftsbericht | NYSE, SPB | |
 |
Electro-Sensors
ELSE
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
China Recycling Energy Corporation
CREG
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Willamette Valley Vineyards
WVVI
|
13.11.2025 | 2025-Q2 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Angion Biomedica Corp.
ANGN
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Aptose Biosciences
APTO
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Sanmina Corporation
SANM
|
13.11.2025 | 2025 | Geschäftsbericht | Nasdaq Global Select Market, SPB | |
 |
Daré Bioscience
DARE
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Aytu BioScience
AYTU
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
NexPoint Real Estate Finance
NREF
|
13.11.2025 | 2025-Q3 | Quartalsbericht | NYSE | |
 |
Datasea
DTSS
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Marker Therapeutics
MRKR
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Oak Valley Bancorp
OVLY
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Adial Pharmaceuticals
ADIL
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Digimarc Corporation
DMRC
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Vuzix Corporation
VUZI
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market, SPB | |
 |
Energous Corporation
WATT
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Vor Biopharma
VOR
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
VolitionRx Limited
VNRX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | NYSE American |  |
 |
VistaGen Therapeutics
VTGN
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
DarioHealth Corp.
DRIO
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Calyxt
CLXT
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Applied Therapeutics
APLT
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market, SPB | |
 |
AmeriServ Financial
ASRV
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Market | |
 |
Nortech Systems Incorporated
NSYS
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Precigen
PGEN
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
EZCORP
EZPW
|
13.11.2025 | 2025 | Geschäftsbericht | Nasdaq Global Select Market | |
 |
Oramed Pharmaceuticals
ORMP
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market | |
 |
Co-Diagnostics
CODX
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Capital Market | |
 |
Luminar Technologies
LAZR
|
13.11.2025 | 2025-Q3 | Quartalsbericht | Nasdaq Global Select Market, SPB | |
Seite anzeigen 6 von 30